MPX Bioceutical Corp — Form D

MPX Bioceutical Corp of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-22. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2018-01-22
Form: D
Accession: 0001728215-18-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $2.5M
Amount sold: $2.5M
Investors: 20
Date of first sale: 2017-01-19
Security types: equity
Revenue range: $1,000,001 - $5,000,000
SEC file number: 021-303844

Issuer

Name: MPX Bioceutical Corp
CIK: 0001728215
Entity type: Corporation
Jurisdiction: ONTARIO, CANADA
Address: 5255 YONGE STREET, SUITE 701, TORONTO, A6, M2N 6P4
Phone: (416) 840-3725

Officers, directors & promoters (11)

Name	Role	Location
W. Scott Boyes	Director	Toronto, A6
Robert R Galvin	Director	Toronto, A6
Andrew R Ryan	Director	Toronto, A6
Richard S Segerblom	Director	Toronto, A6
Randall G Stafford	Director	Toronto, A6
Elizabeth M Stavola	Director	Toronto, A6
Miles D Thompson	Director	Toronto, A6
W. Scott Boyes	Executive Officer	Toronto, A6
Jeremy S Budd	Executive Officer	Toronto, A6
David S McLaren	Executive Officer	Toronto, A6
Elizabeth M Stavola	Executive Officer	Toronto, A6

More